New flu vaccine trial aims to protect moms and babies
NCT ID NCT07211152
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new flu vaccine in 150 healthy pregnant women aged 18-39, between 20 and 32 weeks of pregnancy. Participants receive either the new vaccine or an existing one, and researchers check immune response and safety for both mother and baby. The goal is to see if the vaccine protects against flu and passes protection to the newborn.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Health Cube Medical Clinics
RECRUITINGMandaluyong, National Capital Region, Philippines
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of the Philippines - Philippine General Hospital (UP-PGH)
RECRUITINGManila, National Capital Region, Philippines
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New mRNA vaccine aims to outsmart flu by targeting its hidden parts
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- One shot to beat the flu? new drug peramivir tested in large trial
- Doctor training aims to boost vaccine rates
- New combo flu pill put to the test in healthy volunteers